GET ALL THE ACCESS
Publications
30/05/2023
Ketamine infusion may be as effective as electroconvulsive therapy (ECT) for individuals with treatment-resistant depression who do not have psychosis. Under certain conditions, it even offers […]
28/05/2023
A new study published in the journal Psychiatry Research suggests that ketamine may be a valid treatment option for individuals with borderline personality disorder (BPD) associated […]
25/05/2023
Electroconvulsive therapy (ECT) is a treatment option for individuals with mental disorders who have not found positive results with traditional methods. Despite its historical association with […]
24/05/2023
One of the most anticipated lectures at the annual meeting of the American Psychiatric Association (APA) in 2023 was given by Dr. John H. Krystal, Director […]
27/04/2023
As more studies demonstrate the therapeutic benefits of psychedelics, these substances should become more prevalent in society.. The question, as Dr. Farrah Jarral wrote in The […]
24/04/2023
Can psychedelics treat Long COVID? A report from Time magazine, written by journalist Jamie Ducharme, sought to answer this question based on the stories of patients […]
18/04/2023
On April 13th, Beneva hosted an Instagram Live with anthropologist Lígia Platero, who studies plant teachers and shamanism. Platero is affiliated with the education program at […]
04/04/2023
The consumption of substances of different types is inherent to human beings. Throughout history, individuals belonging to different cultures, societies, and civilizations have sought pleasurable sensations […]
04/04/2023
Ibogaine is a substance extracted from the root of the iboga, a shrub that grows in West Africa. For thousands of years, it has been used […]
27/03/2023
A case study found that microdosing ibogaine reduced the effects of severe bipolar depression within 15 days. Published in the Brazilian Journal of Psychiatry, the work, […]